Liquid immediate release pharmaceutical formulation comprising an acid addition salt of a substituted azetidine derivative compound and a pharmaceutically acceptable diluent or carrier useful for the treatment or prevention of thrombosis.
Номер патента: CL2008003324A1
Опубликовано: 06-03-2009
Автор(ы): Alami Susanna Abrahamsen, Anders Magnusson, Carl-Gustaf Sigfridsson, Mikael Thune, Tord Inghardt
Принадлежит: AstraZeneca AB
Опубликовано: 06-03-2009
Автор(ы): Alami Susanna Abrahamsen, Anders Magnusson, Carl-Gustaf Sigfridsson, Mikael Thune, Tord Inghardt
Принадлежит: AstraZeneca AB
Реферат: Formulación farmacéutica líquida de liberación inmediata que comprende una sal de adición de ácido de un compuesto derivado de azetidina sustituido y un diluyente o portador farmacéuticamente aceptable, útil para el tratamiento o prevención de trombosis (divisional de la Sol. 1067-03). Immediate release liquid pharmaceutical formulation comprising an acid addition salt of a substituted azetidine derivative compound and a pharmaceutically acceptable diluent or carrier useful for the treatment or prevention of thrombosis (divisional de la Sol. 1067-03).
Pharmaceutical formulations of desmopressin
Номер патента: US09919025B2. Автор: Anders Nilsson,Hans Lindner,Jorgen Wittendorff. Владелец: FERRING BV. Дата публикации: 2018-03-20.